Perrigo Company plc
NYSE: PRGO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Patrick Lockwood-Taylor
- Employees
- 8,325
- Headquarters
- Dublin, Ireland
- IPO year
- 1991
- Market cap
- $1.4B
- Website
- https://www.perrigo.com
Loading PRGO…
Loading profile data…Frequently asked questions about PRGO
What does Perrigo Company plc (PRGO) do?
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutr...
Where does PRGO trade?
Perrigo Company plc (PRGO) trades on the New York Stock Exchange.
What sector is PRGO in?
Perrigo Company plc (PRGO) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Perrigo Company plc?
Patrick Lockwood-Taylor is the chief executive officer of Perrigo Company plc (PRGO).
Where is Perrigo Company plc headquartered?
Perrigo Company plc is headquartered in Ireland.
Does PRGO pay a dividend?
Yes — Perrigo Company plc (PRGO) paid a trailing twelve-month dividend of USD 1.16 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did PRGO go public?
Perrigo Company plc (PRGO) completed its initial public offering in 1991.